Acer Therapeutics

Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Fri, 03/17/23 - 11:41 am
Acer Therapeutics
clinical trials
hot flashes
menopause
osanetant
FDA approves Acer’s olpruva to treat urea cycle disorders
Pharmaceutical Business Review
Wed, 12/28/22 - 08:34 pm
FDA
Acer Therapeutics
olpruva
urea cycle disorders
Rare disease outfit Acer fumbles at FDA, receiving CRL due to lack of inspection readiness at packaging manufacturer
Endpoints
Tue, 06/21/22 - 11:02 am
Acer Therapeutics
ACER-001
urea cycle disorders
FDA
complete response letter
FDA rejects Acer's rare disease drug, asks for new trial — shares crate
Endpoints
Wed, 06/26/19 - 10:11 am
Acer Therapeutics
celiprolol
hypertension
clinical trials
FDA
Ehlers-Danlos syndrome
Edsivo
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
Mon, 06/24/19 - 07:27 pm
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
FDA sets summer PDUFA dates for Acer, Kala therapies
BioCentury
Fri, 12/28/18 - 01:16 pm
FDA
Acer Therapeutics
Kala Pharmaceuticals
Edsivo celiprolol
KPI-121